Mesoblast raises $138m on hopes for COVID-19 treatment
MELBOURNE: Stem cell biotech Mesoblast is predicting its much-hyped potential treatment for the coronavirus will
MELBOURNE: Stem cell biotech Mesoblast is predicting its much-hyped potential treatment for the coronavirus will